Article

jdsupra.com on 2018-06-18 20:40

FDA Issues Final Guidance Documents Relating to Medical Product Manufacturer Communications

On June 12, 2018, the Food and Drug Administration (“FDA”) issued two key documents outlining the agency’s current thinking regarding drug and device ...

Related news

FDA Issues Three Key Documents Relating to Medical Product Manufacturer Communications jdsupra.com
United States , Washington , Cures
FDA Issues Guidance on Drug and Device Manufacturer Communications: Part II – Medical Product Communications that are Consistent with the FDA-Required Labeling jdsupra.com
California , United States , Switzerland
Blog: FDA Finalizes Two Guidance Documents Regarding Medical Product Communications jdsupra.com
California , United States , Switzerland
FDA Finalizes Guidance on Payor Communications jdsupra.com
California , United States , Switzerland
FINRA Issues New Guidance Regarding Customer Communications Relating to Departing Registered Representatives jdsupra.com
California , United States , Switzerland
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer jdsupra.com
California , United States , Switzerland
FDA guidances promote greater communication to payors about medical product value, clarify CFL communications jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance On Biosimilar Licensure For Fewer Than All Conditions Licensed for Reference Product jdsupra.com
California , United States , Switzerland
Drug test manufacturer seeking FDA approval for new product bizjournals.com
New Jersey , United States
FDA Issues Guidance on Drug and Device Manufacturer Communications: Part I – Health Care Economic Information and Unapproved Products/Use Communications with Payors jdsupra.com
California , United States , Switzerland
Not So Clean After All: FDA Takes Aim at Manufacturer of OTC Hand Sanitizer Product Line Making Disease Prevention Claims from Ebola to the Flu jdsupra.com
California , United States , Switzerland
FDA resumes enforcement relating to laboratory developed tests jdsupra.com
California , United States , Switzerland
FDA proposes streamlining combination product regulations jdsupra.com
California , United States , Switzerland
FDA Finalizes New Definition of Biological Product jdsupra.com
California , United States , Switzerland
FDA Guidance on DSCSA Product Identifier Requirements jdsupra.com
California , United States , Switzerland
FDA Issues Final Definition for “Biological Product”jdsupra.com
California , United States , Switzerland
Lessons From FDA’s Warning Letter to Stem Cell Product Manufacturer jdsupra.com
California , United States , Switzerland
FDA Publishes Two Key Guidance Documents on Cosmetics Facility Registration and Product Listing jdsupra.com
United States
FDA and Life Sciences FDA Finalizes Guidances for “Consistent Communications” and Payor Communications jdsupra.com
California , United States , Switzerland
FDA Finalizes Nutrition Labeling Guidance Documents jdsupra.com
California , United States , Switzerland